Siklos European Union - English - EMA (European Medicines Agency)

siklos

theravia - hydroxycarbamide - anemia, sickle cell - antineoplastic agents - siklos is indicated for the prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in paediatric and adult patients suffering from symptomatic sickle-cell syndrome.

Xromi European Union - English - EMA (European Medicines Agency)

xromi

nova laboratories ireland limited - hydroxycarbamide - anemia, sickle cell - antineoplastic agents - prevention of vaso-occlusive complications of sickle cell disease in patients over 2 years of age

HYDROXYUREA MEDAC 500 MG Israel - English - Ministry of Health

hydroxyurea medac 500 mg

tzamal bio-pharma ltd - hydroxycarbamide - capsules - hydroxycarbamide 500 mg - hydroxycarbamide - treatment of patient with chronic myeloid leukaemia (cml) in the chronic or accelerated phase of the disease.treatment of patients with essential thrombocytaemia or polycythaemia vera with a high risk for thrmboembolic complications.

Hydrea 500 mg Hard Capsules Ireland - English - HPRA (Health Products Regulatory Authority)

hydrea 500 mg hard capsules

bristol-myers squibb pharmaceuticals uc - hydroxycarbamide - capsule, hard - 500 milligram(s) - other antineoplastic agents; hydroxycarbamide

Hydrea 500 mg Hard Capsules Ireland - English - HPRA (Health Products Regulatory Authority)

hydrea 500 mg hard capsules

cheplapharm arzneimittel gmbh - hydroxycarbamide - capsule, hard - other antineoplastic agents; hydroxycarbamide